The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
Open accessAbstract
The eukaryotic translation initiation factor eIF4E is deregulated in many human cancers, and its overexpression in cells leads to malignant transformation. Oncogenic properties of eIF4E are directly linked to its ability to bind 7-methyl guanosine of the 5′ mRNA. Here, we observe that the antiviral guanosine analogue ribavirin binds to eIF4E with micromolar affinity at the functional site used by 7-methyl guanosine mRNA cap, competes with eIF4E:mRNA binding, and, at low micromolar concentrations, selectively disrupts eIF4E subcellular organization and transport and translation of mRNAs posttranscriptionally regulated by eIF4E, thereby reducing levels of oncogenes such as cyclin D1. Ribavirin potently suppresses eIF4E-mediated oncogenic transformation of murine cells in vitro , of tumor growth of a mouse model of eIF4E-dependent human squamous cell carcinoma in vivo , and of colony formation of eIF4E-dependent acute myelogenous leukemia cells derived from human patients. These findings describe a specific, potent, and unforeseen mechanism of action of ribavirin. Quantum mechanical and NMR structural studies offer directions for the development of derivatives with improved cytostatic and antiviral properties. In all, ribavirin's association with eIF4E may provide a pharmacologic means for the interruption of posttranscriptional networks of oncogenes that maintain and enhance neoplasia and malignancy in human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Budavari, S. (1998) · Royal Society of Chemistry eBooks · Cited by 2,741
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
Sidwell, R. W., Huffman, J. H., Khare, L., Allen, B., Witkowski, R., & Robins, K. (1972) · Science · doi:10.1126/science.177.4050.705 · Cited by 985
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
RNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 820
Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., & Burley, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80280-9 · Cited by 678
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 644
Rousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L., & Sonenberg, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1065 · Cited by 399
Coupled Transcription and Translation Within Nuclei of Mammalian Cells
Iborra, F. J., Jackson, D. A., & Cook, P. R. (2001) · Science · doi:10.1126/science.1061216 · Cited by 382
Niedzwiecka, A., Marcotrigiano, J., Stepinski, J., Jankowska-Anyszka, M., Wyslouch-Cieszynska, A., Dadlez, M., Gingras, A.-C., Mak, P., Darzynkiewicz, E., Sonenberg, N., et al. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00328-5 · Cited by 380
eIF4E expression in tumors: its possible role in progression of malignancies
De Benedetti, A., & Harris, A. L. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00132-0 · Cited by 324
Maag, D., Castro, C., Hong, Z., & Cameron, C. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100349200 · Cited by 281
Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis
Weinstein, I. B. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.857 · Cited by 268
Ribavirin's antiviral mechanism of action: lethal mutagenesis?
Crotty, S., Cameron, C., & Andino, R. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0308-0 · Cited by 248
The mRNA cap-binding protein eIF4E in post-transcriptional gene expression
von der Haar, T., Gross, J. D., Wagner, G., & McCarthy, J. E. G. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb779 · Cited by 233
Graff, J. R., & Zimmer, S. G. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022943419011 · Cited by 215
Topisirovic, I., Guzman, M. L., McConnell, M. J., Licht, J. D., Culjkovic, B., Neering, S. J., Jordan, C. T., & Borden, K. L. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.8992-9002.2003 · Cited by 206
Self-citationPML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
Cohen, N. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4547 · Cited by 188
The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas
Kerekatte, V., Smiley, K., Hu, B., Smith, A., Gelder, F., & De Benedetti, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640107 · Cited by 177
Rosenwald, I. B., Chen, J.-J., Wang, S., Savas, L., London, I. M., & Pullman, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202563 · Cited by 174
Topisirovic, I. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg069 · Cited by 171
Self-citationStructural basis of m7GpppG binding to the nuclear cap-binding protein complex
Calero, G., Wilson, K. F., Ly, T., Rios-Steiner, J. L., Clardy, J. C., & Cerione, R. A. (2002) · Nature Structural Biology · doi:10.1038/nsb874 · Cited by 169
Zimmer, S. G., Benedetti, A. D., & Graff, J. R. (2000) · PubMed · Cited by 164
Kentsis, A., Dwyer, E. J. C., Perez, J. M., Sharma, M., Chen, A., Pan, Z. Q., & Borden, K. L. B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5003 · Cited by 152
Self-citationmRNA Cap-1 Methyltransferase in the SARS Genome
von Grotthuss, M., Wyrwicz, L. S., & Rychlewski, L. (2003) · Cell · doi:10.1016/s0092-8674(03)00424-0 · Cited by 140
Nuclear Eukaryotic Initiation Factor 4e (Eif4e) Colocalizes with Splicing Factors in Speckles
Dostie, J., Lejbkowicz, F., & Sonenberg, N. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.239 · Cited by 136
The emerging roles of translation factor eIF4E in the nucleus
Strudwick, S., & Borden, K. L. B. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700102.x · Cited by 132
Self-citationDwyer, E. J. C., Lai, H., MacDonald, R. C., Salvato, M. S., & Borden, K. L. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3293-3300.2000 · Cited by 132
Self-citationMechanisms of Action of Ribavirin in Antiviral Therapies
Tam, R. C., Lau, J. Y. N., & Hong, Z. (2001) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020101200501 · Cited by 130
Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas
Nathan, C. O., Carter, P., Liu, L., Li, B. D. �., Abreo, F. W., Tudor, A., Zimmer, S. G., & Benedetti, A. D. (1997) · Oncogene · doi:10.1038/sj.onc.1201272 · Cited by 122
Control of biochemical reactions through supramolecular RING domain self-assembly
Kentsis, A., Gordon, R. E., & Borden, K. L. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608799 · Cited by 112
Self-citationInternal Ribosome Entry Site-Mediated Translation in Hepatitis C Virus Replication
Rijnbrand, R. C. A., & Lemon, S. M. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_5 · Cited by 111
DeFatta, R. J., Nathan, C. O., & Benedetti, A. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00007 · Cited by 100
Colomer, R., Lupu, R., Bacus, S. S., & Gelmann, E. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.405 · Cited by 99
Capili, A. D., Edghill, E. L., Wu, K., & Borden, K. L. B. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.035 · Cited by 96
Self-citationPleiotropic mechanisms of ribavirin antiviral activities
Hong, Z., & Cameron, C. E. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8171-5_2 · Cited by 80
Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients
Zoulim, F., Haem, J., Ahmed, S., Chossegros, P., Habersetzer, F., Chevallier, M., Bailly, F., & TREPO, C. G. (1998) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1998.00099.x · Cited by 65
Topisirović, I., Capili, A. D., & Borden, K. L. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6183-6198.2002 · Cited by 61
Self-citationGraff, J. R., Benedetti, A. D., Olson, J. W., Tamez, P. A., Casero, R. A., & Zimmer, S. G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7592 · Cited by 47
Poliovirus translation: A paradigm for a novel initiation mechanism
Sonenberg, N., & Pelletier, J. (1989) · BioEssays · doi:10.1002/bies.950110504 · Cited by 42
Competitive PCR to detect eIF4E gene amplification in head and neck cancer
Sorrells, D. L., Ghali, G. E., Meschonat, C., DeFatta, R. J., Black, D. R., Liu, L., Benedetti, A. D., Nathan, C. O., & Li, B. D. �. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199901)21:1<60::aid-hed8>3.0.co;2-j · Cited by 34
Wang, Y., Sha, M., Ren, W. Y., van Heerden, A., Browning, K. S., & Goss, D. J. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(96)00119-7 · Cited by 14
Cited by
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
Mechanisms of action of ribavirin against distinct viruses
Graci, J. D., & Cameron, C. E. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.483 · Cited by 549
Cellular IRES-mediated translation: The war of ITAFs in pathophysiological states
Komar, A. A., & Hatzoglou, M. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14472 · Cited by 415
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2789 · Cited by 367
Metadata
- Authors
- Kentsis, A., Topisirovic, I., Culjkovic, B., Shao, L., & Borden, K. L. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-12-15
- Volume
- 101
- Issue
- 52
- Pages
- 18105-18110
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2033489247
- Cited by
- 305
- References
- 46
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.